Citadel Advisors’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.66M Buy
+227,385
New +$2.06M ﹤0.01% 6509
2025
Q4
Sell
-83,434
Closed -$863K 13640
2025
Q3
$1.02M Buy
+83,434
New +$876K ﹤0.01% 7513
2025
Q2
Sell
-397,685
Closed -$2.79M 14263
2025
Q1
$2.89M Buy
397,685
+202,144
+103% +$1.47M ﹤0.01% 4832
2024
Q4
$1.35M Sell
195,541
-597,052
-75% -$4.11M ﹤0.01% 6439
2024
Q3
$5.84M Buy
792,593
+600,152
+312% +$5.61M ﹤0.01% 3702
2024
Q2
$2.03M Sell
192,441
-225,635
-54% -$2.86M ﹤0.01% 5275
2024
Q1
$5.78M Sell
418,076
-112,188
-21% -$1.75M ﹤0.01% 3719
2023
Q4
$10.3M Sell
530,264
-412,995
-44% -$7.62M ﹤0.01% 2802
2023
Q3
$20M Buy
943,259
+477,858
+103% +$12.4M ﹤0.01% 1856
2023
Q2
$15.5M Buy
465,401
+280,015
+151% +$10.3M ﹤0.01% 2145
2023
Q1
$7.29M Buy
185,386
+66,505
+56% +$2.76M ﹤0.01% 3224
2022
Q4
$5.01M Sell
118,881
-9,515
-7% -$366K ﹤0.01% 3858
2022
Q3
$4.29M Sell
128,396
-15,056
-10% -$627K ﹤0.01% 4131
2022
Q2
$6.21M Buy
143,452
+52,971
+59% +$2.43M ﹤0.01% 3411
2022
Q1
$4.33M Sell
90,481
-275,973
-75% -$13.7M ﹤0.01% 4458
2021
Q4
$18.6M Buy
366,454
+231,080
+171% +$10.3M ﹤0.01% 2114
2021
Q3
$5.48M Buy
135,374
+94,180
+229% +$4.77M ﹤0.01% 4135
2021
Q2
$2.33M Sell
41,194
-29,555
-42% -$1.68M ﹤0.01% 6210
2021
Q1
$3.74M Sell
70,749
-3,020
-4% -$165K ﹤0.01% 4923
2020
Q4
$4.03M Sell
73,769
-53,840
-42% -$2.83M ﹤0.01% 4048
2020
Q3
$6.39M Buy
127,609
+32,868
+35% +$1.56M ﹤0.01% 2820
2020
Q2
$3.62M Buy
94,741
+62,138
+191% +$2M ﹤0.01% 3545
2020
Q1
$712K Sell
32,603
-183,256
-85% -$5.51M ﹤0.01% 5906
2019
Q4
$8.85M Sell
215,859
-52,191
-19% -$2.13M ﹤0.01% 2333
2019
Q3
$11.4M Sell
268,050
-369,778
-58% -$15.5M 0.01% 2067
2019
Q2
$31.5M Buy
637,828
+428,878
+205% +$21.8M 0.01% 1028
2019
Q1
$10M Buy
208,950
+153,234
+275% +$9.29M 0.01% 2076
2018
Q4
$3.42M Sell
55,716
-59,831
-52% -$4.04M ﹤0.01% 3339
2018
Q3
$9.52M Buy
115,547
+102,147
+762% +$8.12M ﹤0.01% 2154
2018
Q2
$1.05M Sell
13,400
-38,355
-74% -$2.97M ﹤0.01% 5140
2018
Q1
$3.81M Buy
51,755
+34,073
+193% +$2.42M ﹤0.01% 2803
2017
Q4
$1.21M Buy
17,682
+3,973
+29% +$257K ﹤0.01% 4388
2017
Q3
$843K Buy
13,709
+6,306
+85% +$387K ﹤0.01% 4555
2017
Q2
$465K Buy
+7,403
New +$422K ﹤0.01% 5227
2017
Q1
Sell
-22,992
Closed -$1.18M 7846
2016
Q4
$1.1M Sell
22,992
-100,819
-81% -$5.65M ﹤0.01% 3726
2016
Q3
$8.02M Buy
123,811
+113,029
+1,048% +$6.35M 0.01% 1561
2016
Q2
$498K Sell
10,782
-14,461
-57% -$582K ﹤0.01% 4493
2016
Q1
$966K Buy
25,243
+19,201
+318% +$635K ﹤0.01% 3536
2015
Q4
$229K Sell
6,042
-198,041
-97% -$7.3M ﹤0.01% 5626
2015
Q3
$8.43M Buy
204,083
+174,483
+589% +$7.49M 0.01% 1478
2015
Q2
$1.4M Buy
29,600
+23,819
+412% +$1.29M ﹤0.01% 3520
2015
Q1
$348K Sell
5,781
-7,627
-57% -$388K ﹤0.01% 5450
2014
Q4
$586K Buy
13,408
+10,954
+446% +$484K ﹤0.01% 4490
2014
Q3
$110K Sell
2,454
-106,977
-98% -$5.69M ﹤0.01% 6317
2014
Q2
$8.09M Buy
109,431
+77,680
+245% +$6.12M 0.01% 1435
2014
Q1
$2.63M Sell
31,751
-19,324
-38% -$1.7M ﹤0.01% 2375
2013
Q4
$7.06M Buy
51,075
+15,700
+44% +$1.85M 0.01% 1437
2013
Q3
$3.39M Sell
35,375
-1,225
-3% -$104K 0.01% 1918
2013
Q2
$2.24M Buy
+36,600
New +$2.03M ﹤0.01% 2387

Other funds holding NUS

Citadel Advisors's NUS Position: Q1 2026 in Review

Citadel Advisors opened a new position in Nu Skin (NUS) in Q1 2026: 227,385 shares worth $1.66M. The stake represents ﹤0.01% of the portfolio and ranks #6509 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in NUS as recently as Q3 2025.

Citadel Advisors first reported a position in NUS in Q2 2013 and has held it in 49 quarters since. The position peaked at $31.5M in Q2 2019. 178 funds tracked by Wall St. Rank hold NUS as of Q1 2026.

  • Citadel Advisors held 227,385 shares of Nu Skin worth $1.66M as of Q1 2026.
  • Nu Skin was a new Citadel Advisors position in Q1 2026.
  • Nu Skin made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6509 holding.
  • Citadel Advisors first reported a position in Nu Skin in Q2 2013 and has held it in 49 quarters since.
  • Citadel Advisors's Nu Skin position peaked at $31.5M in Q2 2019.
  • 178 funds tracked by Wall St. Rank held Nu Skin as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.